The owner of IBS Tales, Sophie Lee, has written a new book called “Sophie’s Story” which chronicles her life dealing with Irritable Bowel Syndrome.
I want to tell the absolute truth about IBS, because the reality of this disorder is so often clouded by embarrassment and myths. Perhaps the most pervasive myth is that IBS means mild diarrhea and nothing more. Many people with no experience of IBS wonder why we have such difficulty in coping with our condition. This book shows why. – Sophie Lee, “Sophie’s Story”
It would appear that “Sophie’s Story” is aiming to be an accurate & detailed account of what life with Irritable Bowel Syndrome is like, even if the truth about IBS isn’t pretty. Her story will probably resonate with many who have had similar frustrating & painful experiences while dealing with Irritable Bowel Syndrome.
Sophie has been kind enough to provide me with a review copy that I will read & then review at a later date. You can purchase the book right now on Amazon
, Amazon UK
. For international orders it’s best to check the IBS Tales website for further details.
Ironwood Pharmaceuticals is seeking approval from the European Medicines Agency for their Irritable Bowel Syndrome drug Linaclotide.
Almirall is the licensee of Linaclotide for European markets. They along with Linaclotide manufacturer, Ironwood Pharmaceuticals, submitted a Marketing Authorization Application to the European Medicines Agency in a bid to gain access to European markets. Along with the application they submitted the results of their Phase III trials showcasing the benefits they feel Linaclotide provides patients who are dealing with Irritable Bowel Syndrome. If approved the drug would be sold under the brand name of Constella. Continue reading “Ironwood’s Irritable Bowel Syndrome Constipation Drug Seeking European Approval” »
Lexicon Pharmaceuticals recently announced their new drug LX1033 passed Phase I drug safety trials allowing it to move forward into Phase II testing.
Lexicon Pharmaceuticals’ LX1033 is a Irritable Bowel Syndrome drug meant for those with diarrhea predominant Irritable Bowel Syndrome symptoms or mixed symptoms that include diarrhea. LX1033 works by targeting the hydroxylase enzyme which is also known as TPH. TPH is essential for the production of serotonin within the body & it comes in two forms TPH1 & TPH2. TPH1 lives mainly in the digestive system, while TPH2 lives in the nervous system & the brain. LX1033 specifically targets TPH1 only & leaves TPH2 alone to avoid nervous system or psychoactive effects. Serotonin levels do seem to play a role in Irritable Bowel Syndrome, but how much is not fully understood. Continue reading “Lexicon Pharmaceuticals Drug LX1033 For Irritable Bowel Syndrome” »
On July 15th the US Department of Veterans Affairs announced that disability regulations will be changing regarding how the Department of Veterans Affairs views Functional Gastrointestinal Disorders(FGIDs/FGIMDs) such as Irritable Bowel Syndrome.
The new regulations will now list FGIDs as being a “presumed” result of military service during operations within Southeast Asia during the Persian Gulf War that occurred in the early 1990s. This essentially means that a veteran making a disability claim should have an easier task of claiming that their Irritable Bowel Syndrome or Functional Dyspepsia(chronic indigestion) was a result of their service, even if symptoms developed after they had left the military. In the past a veteran had to prove that their symptoms were apparent while they were actively serving during the Gulf War. This made it complicated for many veterans who developed severe gastrointestinal disorders after their tours of duty ended. Continue reading “US Veterans Affairs Disability Regulations More Accepting of IBS” »
Health Canada is strengthening the required side effect warnings on prescriptions of Reglan so that they include more information regarding the likelihood of someone developing debilitating Tardive dyskinesia.
Reglan is the brand name of the drug Metoclopramide which has been used for decades to as an anti-emetic & prokinetic drug. Health Canada is the department which sets health policy within Canada. Health Canada has come out with stronger warnings regarding the major side effect of Tardive dyskinesia. The new warnings will now be required for all prescriptions of Reglan. Continue reading “Reglan Tardive Dyskinesia Side Effect Warnings Boosted In Canada” »
About a month ago I contacted my local congressman, David Wu, asking for his support on “H.R. 2239 – Functional GI and Motility Disorders Research Enhancement Act of 2011“. He recently sent a response back outlining his views on the pending legislation.
Just to recap here is the original letter I sent to David Wu via his website.
I would just like to bring your attention to the house bill HR 2239 “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011”.
I have personally suffered from Irritable Bowel Syndrome for 14 years and went through an acute case of Gastroparesis for 3 months. Both of these diseases have had a profound & lasting affect on my life. Motility related digestive illnesses greatly affect a person’s quality of life & they greatly impact a person’s social, educational & career endeavors. With almost 20% of Americans facing some form of digestive motility disorder, it’s a shame that there isn’t more funding given to researching these diseases.
I ask that you please become a cosponsor of H.R. 2239 by contacting Amy Bos in the office of Congressman James Sensenbrenner, Jr.
Thank you,
Gabriel Hedges Continue reading “David Wu Responds To My H.R. 2239 Inquiry” »
A recent minor spat between the University of Iowa & the University of Melbourne brings awareness to the roles that prunes, sorbitol & FODMAPs play in Irritable Bowel Syndrome.
Prunes were the topic of discussion in a recent debate over their effectiveness in treating Irritable Bowel Syndrome constipation. The debate started over a bit of research done by the University of Iowa’s Department of Gastroenterology which suggested that prunes were possibly a more effective treatment option than psyllium husks for those with Irritable Bowel Syndrome constipation. Continue reading “Irritable Bowel Syndrome & The Great Prune Debate” »
Today we’re investigating one the body’s most vital minerals, magnesium. We’ll be taking a look at two different magnesium supplements: Nature’s Bounty 500mg Magnesium tablets & Nature’s Way 500mg Magnesium Complex capsules.
Magnesium plays an important role in many functions of the human body. It has been linked to helping prevent osteoporosis, diabetes, anxiety, migraines, indigestion, constipation and other ailments. Magnesium is also important for activation of cellular energy(ATP,Adenosine triphosphate). While magnesium is one of the most common elements in the human body most people do not intake enough magnesium on a daily basis. Continue reading “Review: Best Magnesium Supplement? Nature’s Bounty Versus Nature’s Way” »
A study done back in May & released at the Digestive Disease Week conference suggests that gastroenteritis caused by viral or bacterial infection may play a key role in triggering Irritable Bowel Syndrome.
Continue reading “Study Suggests Infection Key To IBS, Especially In Military” »
HR 2239 “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011” could increase funding for disease like Gastroparesis or Irritable Bowel Syndrome.
Visit Functional GI and Motility Disorders Research Enhancement Act of 2011 on Facebook.
Everyone out there who is dealing with a functional gastrointestinal and motility disorder(FGIMD) needs to listen up & get the word out to their friends, family & especially their local US district representative about H.R. 2239 the “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011“. The goal of the bill is to increase funding for functional & motility related gastrointestinal diseases. Continue reading “Please Support HR 2239 “Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2011”” »